{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:01:46Z","timestamp":1790726506712,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":174,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02654","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:47:01Z","timestamp":1782373621000},"page":"e02654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cefepime resistance with preserved ceftriaxone susceptibility in Proteus mirabilis osteomyelitis associated with blaOXA-1 gene amplification: Two case reports with genomic analysis"],"prefix":"10.1016","volume":"45","author":[{"given":"Amorce","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekina","family":"Gonzalez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Allyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idcr.2026.e02654_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","article-title":"Osteomyelitis","volume":"31","author":"Schmitt","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02654_bib2","first-page":"395","article-title":"Osteomyelitis: diagnosis and treatment","volume":"104","author":"Bury","year":"2021","journal-title":"Am Fam Physician"},{"issue":"9431","key":"10.1016\/j.idcr.2026.e02654_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.idcr.2026.e02654_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae104","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02654_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1756-185X.2009.01397.x","article-title":"Proteus vertebral osteomyelitis","volume":"12","author":"Yong","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02654_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13256-021-02890-7","article-title":"Proteus mirabilis thoracic vertebral osteomyelitis: a case report","volume":"15","author":"Chiang","year":"2021","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02654_bib7","article-title":"An unusual case of Proteus mirabilis-Induced severe contiguous bacterial osteomyelitis in an elderly nursing home resident: a case report","volume":"16","author":"McNally","year":"2024","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.idcr.2026.e02654_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jama.1967.03130200068011","article-title":"Neonatal osteomyelitis due to Proteus mirabilis","volume":"202","author":"Levy","year":"1967","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02654_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s004310050547","article-title":"Spinal osteomyelitis caused by Proteus mirabilis in a child","volume":"156","author":"de Weerd","year":"1997","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02654_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005595","article-title":"Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads","volume":"13","author":"Wick","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02654_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009802","article-title":"Polypolish: Short-read polishing of long-read bacterial genome assemblies","volume":"18","author":"Wick","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"10.1016\/j.idcr.2026.e02654_bib12","article-title":"Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification","volume":"7","author":"Schwengers","year":"2021","journal-title":"Microb Genom"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02654_bib13","article-title":"MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies","volume":"4","author":"Robertson","year":"2018","journal-title":"Microb Genom"},{"key":"10.1016\/j.idcr.2026.e02654_bib14","unstructured":"Li, H., Aligning sequence reads, clone sequences and assembly contigs with BW-MEM. 2013. V2: p. arXiv:1303.3997."},{"issue":"2","key":"10.1016\/j.idcr.2026.e02654_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02654_bib16","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1038\/s41467-020-18668-2","article-title":"Piperacillin\/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla(TEM-1B)","volume":"11","author":"Hubbard","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.idcr.2026.e02654_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1074612","article-title":"Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China","volume":"14","author":"Qiao","year":"2023","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.idcr.2026.e02654_bib18","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.47.7.2242-2248.2003","article-title":"Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02654_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0017-2013","article-title":"Proteus mirabilis and Urinary Tract Infections","volume":"3","author":"Schaffer","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.idcr.2026.e02654_bib20","article-title":"Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant Proteus mirabilis isolates","volume":"13","author":"Li","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02654_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/40.3.365","article-title":"Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams","volume":"40","author":"Villar","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02654_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13020266","article-title":"The Detection of Extensively Drug-Resistant Proteus mirabilis Strains Harboring Both VIM-4 and VIM-75 Metallo-\u03b2-Lactamases from Patients in Germany","volume":"13","author":"Fritzenwanker","year":"2025","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02654_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)","volume":"78","author":"Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02654_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1089\/mdr.2019.0066","article-title":"Antimicrobial Susceptibility and Molecular Epidemiology of Proteus mirabilis Isolates from Three Hospitals in Northern Taiwan","volume":"25","author":"Lin","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.idcr.2026.e02654_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotno.2025.07.001","article-title":"Emergence of \u03b2-lactamase-producing Proteus mirabilis in clinical settings: A genotypic investigation of resistance mechanisms and carbapenemase genes bla (NDM-1) and bla (KPC-2)","volume":"6","author":"Joseph","year":"2025","journal-title":"Biotechnol Notes"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02654_bib26","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1128\/AAC.45.6.1615-1620.2001","article-title":"Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa","volume":"45","author":"Aubert","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02654_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2007.11.004","article-title":"High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase","volume":"31","author":"Koh","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02654_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/mdr.2015.0122","article-title":"Reduced susceptibility to Cefepime in clinical isolates of enterobacteriaceae producing OXA-1 beta-lactamase","volume":"22","author":"Torres","year":"2016","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.idcr.2026.e02654_bib29","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1469-0691.1997.tb00649.x","article-title":"Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility","volume":"3","author":"Javier","year":"1997","journal-title":"Clin Microbiol Infect"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:15:02Z","timestamp":1790723702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926001678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"alternative-id":["S2214250926001678"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02654","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefepime resistance with preserved ceftriaxone susceptibility in Proteus mirabilis osteomyelitis associated with blaOXA-1 gene amplification: Two case reports with genomic analysis","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02654"}}